Marksans Pharma - Quarterly Results
13th Feb 2023

The company's total revenue for the quarter ended December 2022 saw a slight change in the total revenue, having registered a total revenue of Rs. 1727.48 millions.A slender decline of -1.67% was recorded to Rs. 256.22  millions from Rs. 260.57 millions in the corresponding previous quarter.A decline of 395.30 millions was observed in the OP in the quarter ended December 2022 from 398.85 millions on QoQ basis.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1727.48 1659.37 4.10 5021.59 4820.11 4.18 6582.89 5995.48 9.80
Other Income 157.14 120.65 30.24 561.80 346.03 62.36 422.51 311.56 35.61
PBIDT 395.30 398.85 -0.89 1253.74 1214.49 3.23 1559.66 1448.68 7.66
Interest 8.48 6.85 23.80 29.56 25.17 17.44 37.95 53.45 -29.00
PBDT 386.82 392.00 -1.32 1224.18 1189.32 2.93 1521.71 1395.23 9.07
Depreciation 41.79 45.21 -7.56 132.27 130.54 1.33 176.63 151.93 16.26
PBT 345.03 346.79 -0.51 1091.91 1058.78 3.13 1345.08 1243.30 8.19
TAX 88.81 86.22 3.00 241.34 233.18 3.50 305.20 259.49 17.62
Deferred Tax 1.56 1.22 27.87 2.50 16.30 -84.66 5.04 -22.39 -122.51
PAT 256.22 260.57 -1.67 850.57 825.60 3.02 1039.88 983.81 5.70
Equity 402.96 409.31 -1.55 409.31 409.31 0.00 409.31 409.31 0.00
PBIDTM(%) 22.88 24.04 -4.80 24.97 25.20 -0.91 23.69 24.16 -1.95